David Adlington from JP Morgan retains his Neutral opinion on the stock. Previously set at EUR 8.60, the target price has been raised to EUR 9.30. | May 11, 2023
In a research note, JP Morgan analyst David Adlington has maintained his recommendation on the stock with a Buy rating. The target price has been raised from EUR 67.20 to EUR 70.80. | May 11, 2023
U.S. bank JPMorgan raised its price target for Synlab to 9.30 euros from 8.60 euros after the lab services provider s figures, but left its rating at Neutral. Despite a good first quarter, headwinds. | May 11, 2023
In a research note published by David Adlington, JP Morgan gives a Neutral rating to the stock. The target price continues to be set at EUR 8.60. | May 10, 2023